Autoimmune Disease
Autoimmune Disease - Related Videos
09:23
Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
0 Views •
Cited by 12 •
2012
The inoculation of Trypanosoma cruzi in fertile eggs prior to incubation renders the parasite kDNA minicircle integration in embryo cells genome. Crossbreeding reveals the vertical transfer of the mutations to progeny. The kDNA integrates into coding regions at several chromosomes and the chickens die with an inflammatory autoimmune heart disease.
08:47
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
0 Views •
Cited by 36 •
2016
This manuscript describes the methods for induction and scoring of the experimental autoimmune encephalomyelitis (EAE) model, together with the assessment of immune cell distribution and mRNA cytokine levels in lymph nodes, spleen, blood and spinal cord using flow cytometry and quantitative PCR, respectively, at various disease phases.
10:38
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
0 Views •
Cited by 4 •
2010
This video shows how to induce autoimmune hypophysitis in SJL mice and how to assess its severity by histopathology.
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
0 Views •
Cited by 31 •
2012
Infection of mice with an Adenovirus expressing the major human autoantigen cytochrome P450 2D6 (hCYP2D6) recognized by sera of patients suffering from type 2 autoimmune hepatitis results in a persistent form of autoimmune-mediated liver disease characterized by extensive hepatitis, fibrosis and generation of a CYP2D6-specific immune response.
10:52
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
0 Views •
Cited by 10 •
2010
Autoimmune hypophysitis can be reproduced in mice by injecting an extract of mouse pituitary proteins.
FAQs
The critical change is a failure of immune tolerance, the biological control that normally prevents responses against self. Once that control is impaired, autoreactive T cells and antibodies can recognize self-antigens as threats. Their activity then engages inflammatory pathways, linking an abnormal recognition event to inflammation, disrupted tissue function, and possible lasting damage.
Autoreactive T cells and antibodies contribute through related but distinct immune components. T cells are cellular responders, whereas antibodies are immune molecules that can recognize self-antigens. Both are identified in the disease process described, and their activation is connected to inflammatory pathways. This interaction helps explain how immune recognition becomes linked to inflammation and tissue disruption.
The distribution of affected tissue differs among autoimmune diseases. Type 1 diabetes illustrates an organ-specific pattern, whereas systemic lupus erythematosus can involve multiple systems. This distinction matters biologically because the location and extent of immune-related damage influence which normal functions become disrupted and why autoimmune disease can produce diverse symptoms and complications.
Studying autoimmune disease advances biology by connecting immune regulation with tissue function. Researchers can examine how loss of tolerance, autoreactive T cells, antibodies, and inflammatory pathways relate to the symptoms and damage seen in affected organs. This work also provides a biological basis for developing diagnostic biomarkers and immunomodulatory treatments.
Developing diagnostic biomarkers applies biological knowledge to the practical challenge of recognizing autoimmune disease. Because these disorders can produce different patterns, including organ-specific and multisystem involvement, biomarker research may help connect immune-related findings with disease assessment. The overview presents these markers as an important route from studying immune regulation toward improved diagnostic support.
Immunomodulatory treatments are relevant because the disease process includes activated immune components and inflammatory pathways that can disrupt tissue function. Research can therefore investigate ways to modify immune activity while limiting damage. Alongside treatment development, studying autoimmune disease supports strategies aimed at preventing tissue injury, making immune regulation a central biological and therapeutic concern.